NasdaqCM:LQDAPharmaceuticals
Liquidia (LQDA) Is Up 15.8% After S&P SmallCap 600 Addition And New YUTREPIA Data - What's Changed
Liquidia Corporation has been added to the S&P SmallCap 600 Index and earlier this week presented four posters at the PHA 2026 International PH Conference in Dallas, including new data from the ASCENT study of its YUTREPIA inhalation powder in pulmonary hypertension associated with interstitial lung disease.
Beyond the index inclusion, the fresh ASCENT and caregiver data highlight how Liquidia is working to shape both clinical practice and broader pulmonary hypertension care models.
Next,...